Phil Holzer
Equibles does not estimate personal net worth.
Get an email with a short summary when Bristol Myers Squibb Co publishes a filing, an earnings call transcript or a press release.
Get BMY alertsAbout Phil Holzer
Bristol Myers Squibb Co reported in an 8-K filed February 15, 2024 that Phil Holzer was appointed Senior Vice President and Controller, effective February 15, 2024. Bristol Myers Squibb Co is classified in the Drug Manufacturers - General industry within the Healthcare sector. Other leadership on record at Bristol Myers Squibb Co includes Christopher Boerner (CEO, COO and Board Member), Christopher Boerner, Ph.D. (CEO, COO and Board Member), David Elkins (CFO) and 6 others.
“Effective February 15, 2024, Mr. Phil Holzer will be appointed Senior Vice President and Controller of Bristol-Myers Squibb Company (the "Company").”
Affiliation history
-
Bristol Myers Squibb Co (BMY)
SEC 8-K
Current2024-02-15–present
Company network
Leadership on record at Bristol Myers Squibb Co
- Christopher Boerner CEO, COO, Board Member
- Christopher Boerner, Ph.D. CEO, COO, Board Member
- David Elkins CFO
- Sandra Leung General Counsel
- Deepak L. Bhatt, M.D., M.P.H. Board Member
- Derica W. Rice Board Member
- Manuel Hidalgo Medina Board Member
- Michael R. McMullen Board Member
- Paula A. Price Board Member